These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 5430389

  • 1. Medical correlates of termination of use of intrauterine contraceptive devices in Taichung.
    Peng JY, Chow LP, Corsa L.
    Int J Fertil; 1970; 15(2):120-6. PubMed ID: 5430389
    [No Abstract] [Full Text] [Related]

  • 2. Experience with intrauterine contraceptive device in Ibadan.
    Ojo OA.
    West Afr Med J Niger Med Dent Pract; 1973 Aug; 22(4):71-7. PubMed ID: 4799783
    [No Abstract] [Full Text] [Related]

  • 3. [Intrauterine devices--adverse effects and the women's evaluation in 1100 cases].
    Weström L.
    Lakartidningen; 1972 Sep 06; 69(37):4131-5. PubMed ID: 5070398
    [No Abstract] [Full Text] [Related]

  • 4. [Results obtained with the simple Lippe's loop, as an intrauterine contraceptive. Study of 2,000 1st insertions with 50,366 months of use].
    Rubio Lotvin B, Ruiz Moreno JA, Bolio Arista R, Alpizar Espejel S.
    Ginecol Obstet Mex; 1974 Jun 06; 35(212):601-9. PubMed ID: 4425123
    [No Abstract] [Full Text] [Related]

  • 5. Hysterography study of long-term effects of intrauterine contraceptive devices.
    Adel SK, Ghoneim MA, Sobrero AJ.
    Fertil Steril; 1971 Oct 06; 22(10):651-62. PubMed ID: 5115103
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic use of the intrauterine contraceptive device.
    Ray JL.
    Int Surg; 1971 Sep 06; 56(3):193-5. PubMed ID: 5105851
    [No Abstract] [Full Text] [Related]

  • 7. The Dalkon Shield intrauterine device.
    Med Lett Drugs Ther; 1972 Dec 22; 14(26):97-8. PubMed ID: 4648573
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intrauterine contraceptive devices upon human uterine contractility.
    Cibils LA.
    J Reprod Med; 1970 Dec 22; 5(6):242-7. PubMed ID: 5521948
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Intrauterine contraception. IV. Experiences and evaluation of the intrauterine contraception].
    Canzler E, Rothe K.
    Dtsch Gesundheitsw; 1971 Jul 08; 26(28):1314-8. PubMed ID: 5096986
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
    Weström L, Bengtsson LP.
    J Reprod Med; 1970 Oct 08; 5(4):154-61. PubMed ID: 4940818
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk of uterine perforation among users of intrauterine devices.
    Heartwell SF, Schlesselman S.
    Obstet Gynecol; 1983 Jan 08; 61(1):31-6. PubMed ID: 6823347
    [Abstract] [Full Text] [Related]

  • 19. [Experimental study of a cupro-contraceptive intrauterine device (copper 7: Gravigarde)].
    Levrier M.
    Gynecologie; 1974 Jan 08; 25(1):35-40. PubMed ID: 4420221
    [No Abstract] [Full Text] [Related]

  • 20. The acceptability of the IUCD.
    Orr BW, Terry JA.
    J R Coll Gen Pract; 1971 Apr 08; 21(105):226-9. PubMed ID: 5576354
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.